Who is coming back for more chlamydia testing within non-specialist health services and where do they go? England, 2013–2016. (March 2020)

• Record Type: Journal Article
• Authors: Harb, A.K.; Town, K.; Callan, E.; Furegato, M.; Connor, N.; Dunbar, J.K.
• Is Part Of: Public health. Volume 180(2020)
• Page Start: 136
• Page End: 140
• Publication Date: 2020-03
• Subjects: Chlamydia re-attendance -- Community settings -- Chlamydia testing venue -- Young adults -- Chlamydia screening; Public health -- Periodicals; Public health -- Periodicals; Electronic journals; 362.1
• DOI: 10.1016/j.puhe.2019.11.010
• Languages: English
• ISSNs: 0033-3506

Abstract

Abstract: Objectives: To investigate patient demographics and venue type preferences within community settings associated with re-attendance for chlamydia testing. Study design: Data used for this analysis were obtained from the English National Chlamydia Screening Programme (NCSP) which focuses on prevention, control and treatment of chlamydia in sexually active under-25 year olds. A greater understanding of how young adults attend services helps to inform commissioners regarding where to focus resources within community settings. Methods: Data from the Chlamydia surveillance system (CTAD) were used to count patient attendances at non-specialist sexual health services (SHSs) among 15–24-year-olds and monitor re-attendance for chlamydia testing within and between community services between 6 and 18 months of their first visit. Results: From January 2013 to December 2016, 866, 847 young people underwent 1, 041, 245 tests for chlamydia. Re-attendance for chlamydia testing was 20.1% (174, 398/866, 847). Re-attendance rate was 28.5% after a positive test and 19.5% after a negative test. For re-attenders, 64.2% used the same venue type for both visits. General practice (GP) and sexual and reproductive health services (SRH) were the most commonly re-attended services (31.0% and 30.6% respectively). Conclusions: Only one in five re-attended for chlamydia testing. Re-attendance was associated with having a positive result, accessibility and convenience. Patients are likely to return for testing to services they know. This should be considered by commissioners implementing new re-attendance guidance based on the NCSP. Highlights: Re-attendance for chlamydia testing (only one in five) was associated with positive results, accessibility and convenience. Re-attendance needs monitoring to evidence whether the current policy of annual testing helps to reduce prevalence. Services should ensure groups with the highest need are aware of and have easy access to chlamydia screening services.